Ashiq K. .2023 .An updated review on rheumatoid arthritis (RA): Epidemiology, pathophysiology, diagnosis, and the current approaches for its treatment. Sudan Journal of Medical Sciences, 18(4) : 51-51.
Khaliq T. .2020 .Clinical profile and treatment outcomes of patients with rheumatoid arthritis at a tertiary care hospital of Pakistan. , 43 : 03.
Shakil M. .2021 .Clinical and hematological parameters in patients of Rheumatoid arthritis in a tertiary care hospital. Rawal Medical Journal, 46(1) : 45-47.
Aletaha D. .2018 .Diagnosis and management of rheumatoid arthritis: a review. J Jama, 320(13) : 1360-72.
Khalil N.Y.,Meloxicam N.Y. .2020 .Profiles of drug substances, excipients and related methodology. Elsevier, : 159-97.
Emam M.F. .2021 .Preparation, characterization and in-Vitro/in-Vivo evaluation of meloxicam extruded pellets with enhanced bioavailability and stability. J Drug Development Industrial Pharmacy, 47(1) : 163-75.
da-Silveira L.M. .2018 .Drug-excipient compatibility assessment of solid formulations containing meloxicam. European Journal of Pharmaceutical Sciences, 112 : 146-51.
Weyna D.R. .2012 .Improving solubility and pharmacokinetics of meloxicam via multiplecomponent crystal formation. J Molecular pharmaceutics, 9(7) : 2094-102.
Khan K.U. .2021 .Synthesis of PEG-4000-copoly (AMPS) nanogels by cross-linking polymerization as highly responsive networks for enhancement in meloxicam solubility. Drug Development Industrial Pharmacy, 47(3) : 465-76.
Parekh V.J. .2017 .Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity. J Drug Development Industrial Pharmacy, 43(4) : 600-10.
.2003 .Stability testing guidelines: stability testing of new drug substances and products. ICH Steering Committee, : 1-24.
Aleksovski A. .2015 .Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. J Expert opinion on drug delivery, 12(1) : 65-84.
Stoltenberg I. .2011 .Orally disintegrating minitablets (ODMTs)-a novel solid oral dosage form for paediatric use. European journal of pharmaceutics biopharmaceutics, 78(3) : 462-9.
Abdelmonem R. .2021 .Formulation and evaluation of baclofen-meloxicam orally disintegrating tablets (ODTs) using co-processed excipients and improvement of ODTs performance using six sigma method. J Drug Design, Development Therapy, : 4383-402.
Chow K. .2008 .Engineering of pharmaceutical materials: An industrial perspective. Journal of pharmaceutical sciences, 97(8) : 2855-77.
Saha S. .2009 .Multifunctional coprocessed excipients for improved tabletting performance. Expert opinion on drug delivery, 6(2) : 197-208.
Garg A. .2013 .Mouth dissolving tablets: a review. J Journal of Drug Delivery Therapeutics, 3(2) : .
Kumbhar P. .2023 .QbD and Six Sigma quality approach for chromatographic estimation of repurposed simvastatin from nanostructured lipid carriers. Microchemical Journal, 185 : 108310.
Mishra S.M. .2017 .An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine. Pharmaceutical development Technology, 22(7) : 889-903.
Seenivasan R. .2024 .Optimizing Metformin HCl manufacturing: A Six Sigma approach to assess process capability. Journal of Applied Pharmaceutical Science, 14(8) : 103-11.
Nisa A.N. .2021 .Determining the release kinetics of risperidone controlled release matrices to treat Schizophrenia. Pak J of Pharm Sci, 43(9) : 1925-34.
Moqbel H.A. .2016 .A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation. Drug Delivery, 23(8) : 2998-3007.
Fouad S.A. .2020 .Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: in-vitro optimization/in-vivo evaluation. J PLoS One, 15(12) : e0244646.
Khan M.A.A. .2022 .. Formulation Development and Evaluation of Oro-Dispersible Tablets Based On Solid Dispersion of Cimetidine. Journal of Drug Delivery Therapeutics, 12 : 42-6.
Akhtar H. .2023 .Quality-by-design based development of fast dispersible nimodipine tablets: Formulation attributes and release kinetic assessment. Pak J of Pharm Sci, 36(2) : .
Higuchi T. J. J. O. P. S. .1963 .Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences, 52(12) : 1145-1149.
Costa P. .2001 .Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 0987(01) : 11297896-24.
. .United States Pharmacopeia 35th Revision-National Formulary 30th Edition USP. Rockville, : 3793-4.
Bowles B.J. .2018 .Co-processed excipients for dispersible tablets-part 1: Manufacturability. J AAPS PharmSciTech, 19 : 2598-609.
Dziemidowicz K. .2018 .Co-processed excipients for dispersible tablets-part 2: patient acceptability. J AAPS PharmSciTech, 19 : 2646-57.
Gohel M. .2005 .A review of co-processed directly compressible excipients. J Pharm Pharm Sci, 8(1) : 76-93.
Takeuchi Y. .2018 .Characterization of mannitol granules and powder: A comparative study using two flowability testers. International Journal of Pharmaceutics, 547(1-2) : 106-13.
Kokott M. .2021 .Evaluation of two novel coprocessed excipients for direct compression of orodispersible tablets and mini-tablets. European Journal of Pharmaceutics Biopharmaceutics, 168 : 122-30.
Manchanda S. .2018 .Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS. Dosage form design considerations: Elsevier, : 773-831.
Yassin S. .2015 .The disintegration process in microcrystalline cellulose based tablets, part 1: influence of temperature, porosity and superdisintegrants. Journal of Pharmaceutical Sciences, 104(10) : 3440-50.
Maqbool U. .2025 .Development and characterisation of fast dispersible dimenhydrinate tablets: Compactional study and in-silico PBPK modeling. Plos one, 20(10) : e0334421.
Chandarana C. .2023 .Measurement of process capability of manufacturing process of Levetiracetam by applying concept of six sigma. Indian J Pharm Educ Res, 57(2) : 386-92.
Adekeye K. .2013 .Evaluating Process Capability Indices for some Quality Characteristics of a Manufacturing Process. Journal of Statistical and Econometric Methods, 2 : 105-14.
Bowles B. J. .2018 .Co-processed excipients for dispersible tablets-part 1: Manufacturability. , 19(6) : 2598-2609.